Douglas Janzen

Douglas Janzen

Amministratore Delegato presso AEQUUS PHARMACEUTICALS INC.

Patrimonio netto: 12 554 $ in data 31/07/2026

58 anni
Health Technology
Finance
Commercial Services

Profilo

Douglas Glen Janzen is the founder of Aequus Pharmaceuticals, Inc., founded in 2013, serving as Chairman, President & Chief Executive Officer.
Mr. Janzen is the founder of Northview LifeSciences, founded in 2014.
Mr. Janzen is the founder of Northview Ventures & Associates General Partnership, founded in 2014, serving as Managing Director.
Current jobs include Chairman at Lexington Biosciences Holdings Corp.
since 2017, Director & Managing Director at LifeSciences British Columbia since 2010, Director at Synaptive Technologies Ltd., Director at Transdermal Research Pharm Laboratories LLC since 2013, and Director at Alabaster Technologies, Inc. Former jobs include President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2010 to 2012, Chairman at AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc. from 2016 to 2021, Chairman at Perimeter Medical Imaging, Inc., Director at Medical Ventures Corp., Director at Teal Valley Health, Inc., Director at Aptamera, Inc., Director at Synaptive Medical, Inc., Director at BIOTECanada, Independent Director at iCo Therapeutics, Inc. from 2012 to 2015, Director at Sentinelle Medical ULC, Independent Director at Neovasc, Inc., Director at BioHEP Technologies Ltd., Director at Renaissance BioScience Corp., Director at AmpHP, Inc., Director at Perimeter Medical Imaging AI, Inc., Analyst at Cormark Securities, Inc. in 2002, President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007, and Head of Research at Loewen, Ondaatje, McCutcheon Ltd. in 2001.
Education includes graduate degree from the University of British Columbia and undergraduate degree from the University of Saskatchewan.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
24/09/2025 12.553.800 ( 9,46% ) 12 554 $ 31/07/2026

Posizioni attive di Douglas Janzen

SocietàPosizioneInizio
AEQUUS PHARMACEUTICALS INC. Amministratore Delegato 03/01/2013
Fondatore 01/04/2014
Alabaster Technologies, Inc.
Direttore/Membro del Consiglio -
Presidente 23/05/2017
Direttore/Membro del Consiglio 03/03/2013
Synaptive Technologies Ltd.
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Fondatore 01/04/2014

Precedenti posizioni note di Douglas Janzen

SocietàPosizioneFine
REGISTERED PLAN PRIVATE INVESTMENTS INC. Presidente 01/12/2021
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Douglas Janzen

Formazione di Douglas Janzen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

52

Relazioni di 1° grado

29

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private29

Finance

Health Technology

Electronic Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Commercial Services

Health Technology

Alabaster Technologies, Inc.

Health Technology

Health Technology

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Douglas Janzen